| 000 | 01604 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250516180725.0 | ||
| 264 | 0 | _c20141007 | |
| 008 | 201410s 0 0 eng d | ||
| 022 | _a1365-2036 | ||
| 024 | 7 |
_a10.1111/apt.12547 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aStättermayer, A F | |
| 245 | 0 | 0 |
_aPolymorphisms of interferon-λ4 and IL28B - effects on treatment response to interferon/ribavirin in patients with chronic hepatitis C. _h[electronic resource] |
| 260 |
_bAlimentary pharmacology & therapeutics _cJan 2014 |
||
| 300 |
_a104-11 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntiviral Agents _xtherapeutic use |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 |
_aHepatitis C, Chronic _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterferons _xtherapeutic use |
| 650 | 0 | 4 |
_aInterleukins _xgenetics |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPolymorphism, Single Nucleotide |
| 650 | 0 | 4 |
_aRibavirin _xtherapeutic use |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aStrassl, R | |
| 700 | 1 | _aMaieron, A | |
| 700 | 1 | _aRutter, K | |
| 700 | 1 | _aStauber, R | |
| 700 | 1 | _aStrasser, M | |
| 700 | 1 | _aBeinhardt, S | |
| 700 | 1 | _aDatz, C | |
| 700 | 1 | _aScherzer, T-M | |
| 700 | 1 | _aSteindl-Munda, P | |
| 700 | 1 | _aGschwantler, M | |
| 700 | 1 | _aTrauner, M | |
| 700 | 1 | _aHofer, H | |
| 700 | 1 | _aFerenci, P | |
| 773 | 0 |
_tAlimentary pharmacology & therapeutics _gvol. 39 _gno. 1 _gp. 104-11 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/apt.12547 _zAvailable from publisher's website |
| 999 |
_c23244472 _d23244472 |
||